Severe pneumococcal pneumonia: impact of new quinolones on prognosis

BACKGROUND: Most guidelines have been proposing, for more than 15 years, a β-lactam combined with either a quinolone or a macrolide as empirical, first-line therapy of severe community acquired pneumonia (CAP) requiring ICU admission. Our goal was to evaluate the outcome of patients with severe CAP,...

Descripción completa

Detalles Bibliográficos
Autores principales: Olive, David, Georges, Hugues, Devos, Patrick, Boussekey, Nicolas, Chiche, Arnaud, Meybeck, Agnes, Alfandari, Serge, Leroy, Olivier
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2011
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3065411/
https://www.ncbi.nlm.nih.gov/pubmed/21406091
http://dx.doi.org/10.1186/1471-2334-11-66

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3065411/
https://www.ncbi.nlm.nih.gov/pubmed/21406091
http://dx.doi.org/10.1186/1471-2334-11-66

Ejemplares similares